Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pro-DexFRA:PDXN -5.56%70 Days Inventory is 144.61 as of Mar. 2026, which is 17% above its 10-year median of 123.13. GuruFocus rates FRA:PDXN with a GF Score™ of 70/100 and a GF Value™ of €36.60 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 787 Medical Devices & Instruments companies, Pro-Dex ranks better than 62.26% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Pro-Dex's Average Total Inventories for the
three
months ended in Mar. 2026 was €18.94 Mil. Pro-Dex's Cost of Goods Sold for the
three
months ended in Mar. 2026 was €11.95 Mil.
Hence, Pro-Dex's Days Inventory for the
three
months ended in Mar. 2026 was 144.61.
The historical rank and industry rank for Pro-Dex's Days Inventory or its related term are showing as below:
FRA:PDXN'
s Days Inventory Range Over the Past 10 Years
Min: 79.74 Med: 123.13 Max: 157.9
Current: 150.7
During the past 13 years, Pro-Dex's highest Days Inventory was 157.90. The lowest was 79.74. And the median was 123.13.
FRA:PDXN's Days Inventory is ranked better than 62.26% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 179.47
vs FRA:PDXN: 150.70
Pro-Dex's Days Inventory
declined
from Mar. 2025 (171.56) to Mar. 2026 (144.61).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Pro-Dex's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.63.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Pro-Dex's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.10.
Pro-Dex (FRA:PDXN) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Pro-Dex's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Pro-Dex's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Pro-Dex Days Inventory Related Terms
Pro-Dex Days Inventory Historical Data
* Premium members only.
The historical data trend for Pro-Dex's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PDXN vs KRMD, EMBC, SMTI: Days Inventory Comparison
For the Medical Instruments & Supplies subindustry, Pro-Dex's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pro-Dex Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Pro-Dex's Days Inventory distribution charts can be found below:
* The bar in red indicates where Pro-Dex's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pro-Dex (FRA:PDXN) has a Days Inventory of 144.61 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Pro-Dex and its competitors. This is 17% above median its historical median of 123.13. Over the past decade, Pro-Dex's Days Inventory has ranged from 79.74 to 157.90. According to the industry distribution chart, Pro-Dex ranks #297 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 37.7%.
Is Pro-Dex's Days Inventory too high?
Pro-Dex's current Days Inventory of 144.61 is 17% above median its 10-year median of 123.13. Over the past 10 years, this metric has ranged from a low of 79.74 to a high of 157.90. The Medical Devices & Instruments industry median Days Inventory is 179.47. Pro-Dex's value of 144.61 is 19.4% below this industry median. Based on the distribution chart, Pro-Dex ranks #297 out of 787 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Pro-Dex has a GF Score™ of 70/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pro-Dex's Days Inventory compare to KRMD and EMBC?
According to the Medical Devices & Instruments industry distribution chart, Pro-Dex ranks #297 out of 787 companies for Days Inventory. This puts Pro-Dex in the upper half of its industry. The industry median Days Inventory is 179.47. Pro-Dex's value of 144.61 is 19.4% below this benchmark. Historically, Pro-Dex's own Days Inventory has ranged from 79.74 to 157.90 over the past decade. While the company's 10-year median is 123.13 vs. the industry median of 179.47, Pro-Dex has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.47, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pro-Dex's current Days Inventory of 144.61 is 19.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Pro-Dex and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pro-Dex's current Days Inventory is 144.61, which is 17% above median its own 10-year median of 123.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pro-Dex stock overvalued right now?
Based on GuruFocus' analysis, Pro-Dex (FRA:PDXN) is currently considered Significantly Overvalued. The stock's GF Value™ is €36.60, compared to a current price of €51.00 — trading 39.3% above its estimated fair value. The current Days Inventory is 144.61, which is 17% above median its 10-year median of 123.13 and 19.4% below the Medical Devices & Instruments industry median of 179.47. Pro-Dex's overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Pro-Dex (FRA:PDXN), the current Days Inventory is 144.61 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pro-Dex (FRA:PDXN) Overvalued in 2026?
Based on GuruFocus' analysis, Pro-Dex stock appears to be overvalued.
The current stock price of €51.00 is trading 39.3% above its estimated GF Value™ of €36.60.
GuruFocus considers Pro-Dex to be Significantly Overvalued.
Key valuation signals for FRA:PDXN:
Days Inventory: 144.61 (17% above median its 10-year median of 123.13)
GF Value™: €36.60 vs. price of €51.00 (39.3% above fair value)
Industry Position: 19.4% below the Medical Devices & Instruments median (#297 of 787)
No single metric tells the full story. See the FRA:PDXN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.
70GF Score
Get the complete analysis for FRA:PDXN
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PDXN has been successfully added to your 
